 | Aenco (AEN)   |
Aenco is a “one stop shop” for the delivery of cutting edge institutional financing, prime brokerage, and smart capital solutions for the HealthTech industry, as well as a research and collaboration hub for healthcare companies and projects involved in the field of blockchain development.
WhitepaperImportant By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice.
What is Aenco
Aeneas is commencing application with an EU/EEA based regulator for a full commercial banking license. Aenco, through the said license, will be able to fully integrate its AEN token and solutions in Europe through the commercial bank.
The AEN token will be integrated as major payment currency and transaction support and also a proof of stake basis for account holding, for the conducting of financial services, which shall include:
- Fiat deposit taking;
- Domestic and cross-border fund remittances;
- Foreign exchange transactions;
- Trade services;
- Investment product distribution and asset management.
Additionally, SmartCap Solutions will include alternative financing solutions primarily focused on Receivables financing, Bridge financing and Collateralized lending.
Aenco Roadmap
Aeneas Capital grante Asset Management license by SFC (Hong Kong).
Fund products generate positive returns throughout subprime crisis.
Assets managed by Aeneas deployed into health care private equity and direct investments.
Aeneas Group builds healthtech partnership with Aptorum Group, a multi-disciplinary medical innovations platform based in HK.
Aeneas Capital initiates to expand its licenses with the SFC in HK to include dealing and advising in securities;
Aeneas expands partnerships with healthtech companies specializing in neuro, infectious diseases, and robotic surgery devices.
Aeneas Capital, LLC. established in New Jersey, U.S.A. to set up a FINRA regulated broker dealer (in progress);
Aeneas Group establishing a full-service banking license in Europe (in progress).
June Initiate Private Sale;
Aeneas Capital granted expanded licenses by the SFC in HK to deal and advise in securities;
Community investors outreach.
Expand team: Developers;
1st pipeline healthtech;
ICO launch;
Launch first generation smart wallet & infrastucture (AEN Connect).
Second generation: AENX trading exchange.
Third generation: AENCO prime brokerage platform;
Ongoing service & expansion of pipeline HealthTech partners.
Token Sale Dates
Presale Period
Token Allocation
Funding Details
Restrictions
China, Hong Kong, Samoa, United States
Token distribution
21% - Company and Team
20% - Reserve and token sale costs
17% - Ecosystem Liquidity
15% - Token Sale
14% - Bonus Allocations
13% - Allocated to Ecosystem Partners / Backers
Funds allocation
40% - Sponsorship and Financial Solutions Platform for HealthTech Partners
30% - Research, Technology Development and Roll Out and Collaboration Research
24% - General Working Capital and Infrastructure Setup Capital Requirement
3% - Marketing & Distribution
3% - Legal & Compliance
Token Price and Payment Options
Project team
Advisors
Social media
Twitter
Discord
Telegram
Reddit
Medium
YouTube
Facebook
LinkedIn
GitHub
BitcointalkIndustries
